Tags : Preclinical Candidates

Takeda Collaborates with Charles River to Identify and Develop Preclinical

Shots: Charles River to receive up front, up to $50M as development milestones/ program, up to $120M as commercial milestones and royalties on net sales of the developed products. Takeda to launch multiple integrated programs targeting its four core therapeutic areas (oncology, gastroenterology, neuroscience, and rare disease) and will get an option to advance the […]Read More